Novo Nordisk A/S (LON:0TDD)
London · Delayed Price · Currency is GBP · Price in USD 59.79
+0.47 (0.79%)
At close: Jan 30, 2026
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 190.4 billion as of January 30, 2026. Its market cap has decreased by -35.96% in one year.
Market Cap
190.40B
Enterprise Value
198.36B
Revenue
36.88B
Ranking
n/a
PE Ratio
15.70
Stock Price
59.79
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 4.46B to 190.40B, an increase of 4,168.72%. That is a compound annual growth rate of 13.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 190.40B | 12.70% |
| Dec 30, 2025 | 168.95B | -45.20% |
| Dec 30, 2024 | 308.32B | -14.91% |
| Dec 29, 2023 | 362.35B | 43.42% |
| Dec 30, 2022 | 252.66B | 33.68% |
| Dec 30, 2021 | 189.00B | 57.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HSBC Holdings | 217.76B |
| AstraZeneca | 208.75B |
| Shell | 159.22B |
| Rio Tinto Group | 113.80B |
| Unilever | 107.78B |
| Rolls-Royce Holdings | 100.39B |
| British American Tobacco p.l.c. | 93.92B |
| GSK plc | 74.30B |